JPY 434.0
(-0.46%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 1.16 Billion JPY | 100.61% |
2022 | 579.6 Million JPY | -66.63% |
2021 | 1.73 Billion JPY | -12.44% |
2020 | 1.98 Billion JPY | 29.37% |
2019 | 1.53 Billion JPY | 8.39% |
2018 | 1.41 Billion JPY | 13.93% |
2017 | 1.24 Billion JPY | 309.32% |
2016 | -593.24 Million JPY | -312.59% |
2015 | -143.78 Million JPY | -128.46% |
2014 | 505.27 Million JPY | -33.05% |
2013 | 754.74 Million JPY | 2.07% |
2012 | 739.41 Million JPY | -54.73% |
2011 | 1.63 Billion JPY | 328.32% |
2010 | 381.34 Million JPY | 422.97% |
2009 | -118.07 Million JPY | 29.52% |
2008 | -167.52 Million JPY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 455.48 Million JPY | 82.61% |
2024 Q3 | 433.24 Million JPY | -4.88% |
2024 Q1 | 249.43 Million JPY | -73.82% |
2023 Q3 | 437.67 Million JPY | 1674.94% |
2023 Q2 | -27.79 Million JPY | 86.63% |
2023 FY | 1.16 Billion JPY | 100.61% |
2023 Q4 | 952.87 Million JPY | 117.71% |
2023 Q1 | -207.86 Million JPY | -678.41% |
2022 FY | 579.6 Million JPY | -66.63% |
2022 Q1 | 449.27 Million JPY | -25.95% |
2022 Q3 | -326.96 Million JPY | -167.6% |
2022 Q2 | 483.69 Million JPY | 7.66% |
2022 Q4 | -26.7 Million JPY | 91.83% |
2021 FY | 1.73 Billion JPY | -12.44% |
2021 Q2 | 577.22 Million JPY | 44.81% |
2021 Q1 | 398.59 Million JPY | -3.53% |
2021 Q3 | 154.41 Million JPY | -73.25% |
2021 Q4 | 606.72 Million JPY | 292.92% |
2020 FY | 1.98 Billion JPY | 29.37% |
2020 Q3 | 978.19 Million JPY | 147.13% |
2020 Q1 | 196.57 Million JPY | -49.16% |
2020 Q2 | 395.82 Million JPY | 101.37% |
2020 Q4 | 413.18 Million JPY | -57.76% |
2019 FY | 1.53 Billion JPY | 8.39% |
2019 Q2 | 542.02 Million JPY | 55.16% |
2019 Q1 | 349.34 Million JPY | -10.76% |
2019 Q3 | 255.35 Million JPY | -52.89% |
2019 Q4 | 386.66 Million JPY | 51.42% |
2018 Q4 | 391.44 Million JPY | -3.55% |
2018 FY | 1.41 Billion JPY | 13.93% |
2018 Q2 | 571.53 Million JPY | 1144.55% |
2018 Q1 | 45.92 Million JPY | -88.39% |
2018 Q3 | 405.83 Million JPY | -28.99% |
2017 Q4 | 395.57 Million JPY | 1941.23% |
2017 FY | 1.24 Billion JPY | 309.32% |
2017 Q3 | -21.48 Million JPY | -106.58% |
2017 Q2 | 326.34 Million JPY | -39.69% |
2017 Q1 | 541.08 Million JPY | 161.47% |
2016 Q1 | 41.74 Million JPY | 157.51% |
2016 FY | -593.24 Million JPY | -312.59% |
2016 Q4 | -880.29 Million JPY | -558.38% |
2016 Q3 | 192.04 Million JPY | 260.58% |
2016 Q2 | 53.26 Million JPY | 27.6% |
2015 Q1 | 36.34 Million JPY | -84.02% |
2015 Q2 | 175.82 Million JPY | 383.74% |
2015 Q3 | -286.37 Million JPY | -262.88% |
2015 FY | -143.78 Million JPY | -128.46% |
2015 Q4 | -72.58 Million JPY | 74.65% |
2014 Q2 | 260.7 Million JPY | 348.05% |
2014 Q1 | 58.18 Million JPY | -70.31% |
2014 FY | 505.27 Million JPY | -33.05% |
2014 Q4 | 227.46 Million JPY | 653.6% |
2014 Q3 | -41.08 Million JPY | -115.76% |
2013 Q3 | 215.76 Million JPY | -33.07% |
2013 Q4 | 195.96 Million JPY | -9.18% |
2013 FY | 754.74 Million JPY | 2.07% |
2013 Q1 | 20.62 Million JPY | -92.9% |
2013 Q2 | 322.38 Million JPY | 1463.29% |
2012 Q3 | 103.31 Million JPY | -56.73% |
2012 Q2 | 238.74 Million JPY | 122.91% |
2012 Q4 | 290.25 Million JPY | 180.94% |
2012 FY | 739.41 Million JPY | -54.73% |
2012 Q1 | 107.1 Million JPY | -24.73% |
2011 Q2 | 1.26 Billion JPY | 462.54% |
2011 FY | 1.63 Billion JPY | 328.32% |
2011 Q1 | 225.19 Million JPY | 11.9% |
2011 Q3 | -947 Thousand JPY | -100.07% |
2011 Q4 | 142.3 Million JPY | 15126.61% |
2010 Q1 | -25.3 Million JPY | -114.31% |
2010 Q3 | 110.99 Million JPY | 17.58% |
2010 Q2 | 94.39 Million JPY | 473.09% |
2010 FY | 381.34 Million JPY | 422.97% |
2010 Q4 | 201.25 Million JPY | 81.33% |
2009 Q3 | 178.77 Million JPY | 163.4% |
2009 Q1 | -191.7 Million JPY | 0.0% |
2009 FY | -118.07 Million JPY | 29.52% |
2009 Q2 | -281.98 Million JPY | -47.09% |
2009 Q4 | 176.84 Million JPY | -1.08% |
2008 FY | -167.52 Million JPY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
HEARTSEED INC | -1.47 Billion JPY | 178.91% |
Cawachi Limited | 4.71 Billion JPY | 75.329% |
Pharmarise Holdings Corporation | -351 Million JPY | 431.266% |
Qol Holdings Co., Ltd. | 4.88 Billion JPY | 76.173% |
MatsukiyoCocokara & Co. | 52.34 Billion JPY | 97.779% |
Welcia Holdings Co., Ltd. | 26.45 Billion JPY | 95.604% |
Create SD Holdings Co., Ltd. | 13.69 Billion JPY | 91.507% |
NIHON CHOUZAI Co.,Ltd. | 2.55 Billion JPY | 54.456% |
COSMOS Pharmaceutical Corporation | 24.45 Billion JPY | 95.245% |
Tsuruha Holdings Inc. | 24.1 Billion JPY | 95.176% |
Ohki Healthcare Holdings Co.,Ltd. | 2.21 Billion JPY | 47.387% |
Satudora Holdings Co.,Ltd. | 470 Million JPY | -147.392% |
Kusuri No Aoki Holdings Co., Ltd. | 12.3 Billion JPY | 90.552% |
Medical System Network Co., Ltd. | 1.86 Billion JPY | 37.487% |
Shinnihonseiyaku Co., Ltd. | 2.39 Billion JPY | 51.431% |
Sugi Holdings Co.,Ltd. | 21.97 Billion JPY | 94.71% |
YAKUODO HOLDINGS Co., Ltd. | 3.82 Billion JPY | 69.601% |
Genky DrugStores Co., Ltd. | 6.32 Billion JPY | 81.614% |
Ain Holdings Inc. | 11.4 Billion JPY | 89.801% |
Sundrug Co.,Ltd. | 29.12 Billion JPY | 96.008% |